AdvisorNet Financial »

Fs Global Cr Opportunitie Fda shares owned by AdvisorNet Financial

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by AdvisorNet Financial from 13F filings

Historical chart of AdvisorNet Financial investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by AdvisorNet Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by AdvisorNet Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $277k 44k 6.35
2024-06-30 $26k 4.0k 6.37
2024-03-31 $24k 4.0k 5.93
2023-12-31 $118k 21k 5.67
2023-09-30 $119k 22k 5.42
2023-06-30 $104k 22k 4.75
2023-03-31 $63k 14k 4.44

More positions owned by AdvisorNet Financial

Spdr Portfolio S&p 500 Etf Etf (SPLG)
Tr Activebeta Us Large Cap Equity Etf Etf (GSLC)
Ishares S&p 500 Index Etf (IVV)
Microsoft Stock (MSFT)
Apple Stock (AAPL)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares Aggregate Bond Etf Etf (AGG)
Schwab Us Dividend Equity Etf Etf (SCHD)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Jpmorgan Ultra-short Income Etf Etf (JPST)
Nvidia Corporation Stock (NVDA)
Dimensional Us Core Equity Market Etf Etf (DFAU)
Ishares Dj Us Technology Etf (IYW)
Vanguard Growth Etf Etf (VUG)

View all positions for AdvisorNet Financial

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Nomura Holdings
Thomas J. Herzfeld Advisors
Wagner Wealth Management
Cetera Investment Advisers
LPL Financial
Envestnet Asset Management
H D Vest Advisory Services
Vista Finance
Rockefeller Capital Management
Advisor Group Holdings
Ellis Investment Partners
Private Advisor
Kestra Advisory Services

View all funds holding Fs Global Cr Opportunitie Fda